Investigation of the anti-inflammatory, antinociceptive effect of ellagic acid as measured by digital paw pressure via the randall-selitto meter in male sprague-dawley rats

AANA Journal

Volumn 79, Issue SUPPL. 4, 2011, Pages

  Gainok, Jeffrey ^a   Daniels, Regina ^b   Golembiowski, David ^b   Kindred, Patricia ^a   Post, Lisa ^c   Strickland, Rob ^d   Garrett, Normalynn ^e  

^a WOMACK ARMY MEDICAL CENTER   (United States)

^b MADIGAN ARMY MEDICAL CENTER   (United States)

^c CARL R DARNALL ARMY MEDICAL CENTER   (United States)

^d Ireland Army Community Hospital   (United States)

^e Akimeka LLC   (United States)

Author keywords

Anti inflammatory; Antinociceptive; Cyclooxygenase; Ellagic acid; Randall Selitto meter

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINOCICEPTIVE AGENT; ELLAGIC ACID; KETOROLAC; MELOXICAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SCREENING; EXPERIMENTAL RAT; HINDLIMB; HYPERALGESIA; INFLAMMATION; LEG PAIN; MALE; NONHUMAN; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PROSPECTIVE STUDY; RAT;

ANIMALS; CYCLOOXYGENASE INHIBITORS; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; ELLAGIC ACID; KETOROLAC; MALE; NOCICEPTION; NOCICEPTIVE PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; THIAZINES; THIAZOLES;

EID: 84860395200     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Pomegranate ranked healthiest fruit juice. CBS Interactive Inc. http://www.cbsnews.com/stories/2008/07/05/earlyshow/health/main4234811.shtml?tag=mncol;1st;1. Accessed May 23, 2011.
2. American Cancer Society. Cancer facts & figures 2008. http://www.cancer.org/Research/CancerFactsFigures/Cancer-Facts-Figures-2008. Accessed May 23, 2011.
3. Bhargava UC, Westfall BA, Siehr DJ. Preliminary pharmacology of ellagic acid from Juglans nigra (black walnut). J Pharm Sci. 1968; 57(10):1728-1732.
4. Girolami A, Fioretti D, Cella G, Pedrazzoli G, Bernardi R. The effect of fibrinolysis inhibitors on the ellagic acid activation of Hageman factor in the dog. Thromb Diath Haemorrh. 1971;26(3):553-564.
5. Cliffton EE, Girolami A, Agostino D. The effect of ellagic acid on the thrombin-induced hemorrhagic syndrome in the rat. Blood. 1966;28 (2):253-257.
6. Botti RE, Ratnoff OD. Studies on the pathogenesis of thrombosis: an experimental "hypercoagulable" state induced by the intravenous injection of ellagic acid. J Lab Clin Med. September 1964;64:385-398.
7. Girolami A, Cliffton EE. Hypercoagulable state induced in humans by the intravenous administration of purified ellagic acid. Thromb Diath Haemorrh. 1967;17(1-2):165-175.
8. Damas J, Adam A, Remacle-Volon G, Grek V. Studies on the vascular and hematological changes induced by ellagic acid in rats. Agents Actions. 1987;22(3-4):270-279.
9. Damas J, Remacle-Volon G. The thrombopenic effect of ellagic acid in the rat: another model of platelet stimulation "in vivo." Thromb Res. 1987;45(2):153-163.
10. Festa F, Aglitti T, Duranti G, Ricordy R, Perticone P, Cozzi R. Strong antioxidant activity of ellagic acid in mammalian cells in vitro revealed by the comet assay. Anticancer Res. 2001;21(6A):3903-3908.
11. Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem. 2006;54(3):980-985.
12. Chiang LC, Ng LT, Chiang W, Chang MY, Lin CC. Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Med. 2003;69(7):600-604.
13. Bhosle SM, Huilgol NG, Mishra KP. Enhancement of radiationinduced oxidative stress and cytotoxicity in tumor cells by ellagic acid. Clin Chim Acta. 2005;359(1-2):89-100.
14. Stoner GD, Chen T, Kresty LA, Aziz RM, Reinemann T, Nines R. Protection against esophageal cancer in rodents with lyophilized berries: potential mechanisms. Nutr Cancer. 2006;54(1):33-46.
15. Verma PR, Joharapurkar AA, Chatpalliwar VA, Asnani AJ. Antinociceptive activity of alcoholic extract of Hemidesmus indicus R.Br. in mice. J Ethnopharmacol. 2005;102(2):298-301.
16. Ray WA, Varas-Lorenzo C, Chung CP, et al. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes. 2009;2(3):155-163.
17. Beltz J, McNeil C, Fisher M, et al. Investigation of the antihyperalgesic effects of the pomegranate extract ellagic acid [abstract]. AANA J. 2008;76(5):365-366. Abstract A6.
18. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther. 1957;111(4):409-419.
19. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev. 2001;53(4):597-652.
20. Dubinsky B, Crew MC, Melgar MD, Karpowicz JK, Di Carlo FJ. Correlation of analgesia with levels of tilidine and a biologically active metabolite in rat plasma and brain. Biochem Pharmacol. 1975;24(2):277-281.
21. Teel RW. Distribution and metabolism of ellagic acid in the mouse following intraperitoneal administration. Cancer Lett. 1987;34(2):165-171.
22. Rogerio AP, Fontanari C, Melo MC, et al. Anti-inflammatory, analgesic and anti-oedematous effects of Lafoensia pacari extract and ellagic acid. J Pharm Pharmacol. 2006;58(9):1265-1273.
23. Ellagic Insurance Formula. Greenwood Health Systems. http://www.ellagic.net/?gclid=ClaYzvzM26gCFQ12gwodTG8XBg. Accessed May 23, 2011.
24. Martignoni M, Groothuis G, de Kanter R. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine. Drug Metab Dispos. 2006;34(6):1047-1054.
25. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther. 1992;263(1):136-146.
26. Zhang Y, Shaffer A, Portanova J, Seibert K, Isakson PC. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production. J Pharmacol Exp Ther. 1997;283(3): 1069-1075.
27. Chellman GJ, Lollini LO, Dorr AE, DePass LR. Comparison of ketorolac tromethamine with other injectable nonsteroidal anti-inflammatory drugs for pain-on-injection and muscle damage in the rat. Hum Exp Toxicol. 1994;13(2):111-117.
28. Padi SS, Naidu PS, Kulkarni SK. Involvement of peripheral prostaglandins in formalin-induced nociceptive behaviours in the orofacial area of rats. Inflammopharmacology. 2006;14(1-2):57-61.
29. Padi SS, Jain NK, Singh S, Kulkarni SK. Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor. Eur J Pharmacol. 2004;491(1):69-76.
30. Randolph BC, Peters MA. Analgesic effectiveness of ketorolac compared to meperidine in the rat formalin test. Anesth Prog. 1997;44(1):11-16.
31. Manual on the Responsible Care and Use of Laboratory Animals. University of Rochester Medical Center, University Committee on Animal Resources. http://www.urmc.rochester.edu/ucar/policies/documents/ucar-manual.doc. Accessed May 23, 2011.
32. Jaeger RM. Statistics. 2nd ed. Thousand Oaks, CA: Sage Publications, Inc; 1993:320-333.
33. Kim MH, Chung J. Synergistic cell death by EGCG and ibuprofen in DU-145 prostate cancer cell line. Anticancer Res. 2007;27(6B):3947-3956.
34. Adhami VM, Malik A, Zaman N, et al. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res. 2007;13(5):1611-1619.
35. Mroszczak EJ, Jung D, Yee J, Bynum L, Sevelius H, Massey I. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy. 1990;10(6 pt 2):33S-39S.
36. Corbett S, Daniel J, Drayton R, Field M, Steinhardt R, Garrett N. Evaluation of the anti-inflammatory effects of ellagic acid. J Perianesth Nurs. 2010;25(4):214-220. doi:10.1016/j.jopan.2010.05.011.
37. Seeram NP, Henning SM, Zhang Y, Suchard M, Li Z, Heber D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr. 2006;136(10):2481-2485.